CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage

Bladder cancer (BCa) is the ninth most commonly diagnosed cancer worldwide. Although there are several well-established molecular and immunological classifications, markers for tumor cells and immune cells that are associated with prognosis are still needed. The chemokine CC motif ligand 2 (CCL2) co...

Descripción completa

Detalles Bibliográficos
Autores principales: Eckstein, Markus, Epple, Elena, Jung, Rudolf, Weigelt, Katrin, Lieb, Verena, Sikic, Danijel, Stöhr, Robert, Geppert, Carol, Weyerer, Veronika, Bertz, Simone, Kehlen, Astrid, Hartmann, Arndt, Wullich, Bernd, Taubert, Helge, Wach, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281525/
https://www.ncbi.nlm.nih.gov/pubmed/32429318
http://dx.doi.org/10.3390/cancers12051253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281525/
https://www.ncbi.nlm.nih.gov/pubmed/32429318
http://dx.doi.org/10.3390/cancers12051253

Ejemplares similares